“This trial brings us closer to realizing ProLectin-M's potential as a first-line antiviral," said Dr. Leslie Ajayi, Bioxytran's Chief Medical Officer. "The consistency of our results, including 100% ...

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...

Structure activity relationship studies reveal that minimal modifications to the dimethylaniline moiety of S656 improve its cyclin K MGD function over CDK inhibition by promoting DDB1 engagement. This ...

In 2020, the estimated market value of a PRV was around $100 million, which exceeds Roche’s spending on clinical trials, as noted by KEI. Since its inception in 2003, the Spinal Muscular Atrophy ...

As the demand for more effective and targeted therapeutics grows to tackle challenging targets, traditional methods—focused on binding rather than function—are no longer sufficient. This white paper ...

(Abstract #2241) IO170, also developed using IO Biotech’s T-win® platform, demonstrated significant tumor growth inhibition in breast and prostate cancer mouse models. The TGF- β-directed ...

Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping ... is expected to enter the clinic next year. The biotech hopes to bring first-in-class therapies to ...

Specifically, this notification establishes the input-output norms for the export product “Doxycycline 100 mg. Dispersible Tablets.” The notice specifies that for the export of one number of ...

Its dysregulation is a well-established oncogenic driver in numerous human cancers. The cancer-related function of cyclin D1 has been primarily studied by focusing on the phosphorylation of the ...

DMC backs continuation of Rezolute's Phase 3 sunRIZE study for congenital hyperinsulinism without raising sample size. Rezolute priced a $90 million stock offering at $3.25/share to fund R&D and ...